Report
Michael Waterhouse
EUR 100.00 For Business Accounts Only

Baxter’s Medication and Nutrition Segment Issues Haunt Firm Again in 3Q Results

Baxter’s supply disruption issues seen previously continued to cause problems during the third quarter and will likely become a more prolonged challenge for the company to remediate. We plan to lower our top-line forecast for this year and 2019 in our model, but the current dynamic doesn’t dramatically shift our long-term thinking for the business. Our operating margin forecast is still in line with management’s 17.1% to 17.3% outlook. Therefore, we expect to leave our fair value estimate and na...
Underlying
Baxter International Inc.

Baxter International, through its subsidiaries, provides a portfolio of healthcare products, including acute and chronic dialysis therapies; sterile intravenous solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision. The company manages its business based on three geographic segments: Americas (North and South America), Europe, Middle East and Africa and Asia-Pacific.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Michael Waterhouse

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch